Acupuncture and Tuina School/The 3rd Teaching Hospital, Chengdu University of Traditional Chinese Medicine, 37# Shierqiao Road, Chengdu, 610075, Sichuan, China.
Acupuncture-Brain Research Center, Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China.
Trials. 2020 Nov 6;21(1):915. doi: 10.1186/s13063-020-04836-8.
Acupuncture has long been used to treat chronic stable angina pectoris (CSAP), but the acupuncture prescription for CSAP varies. This trial will compare the therapeutic effects between the acupoints on the Heart Meridian and the acupoints on the Lung Meridian for treating CSAP, so as to provide a better prescription for acupuncture treatment of CSAP.
This is a multicenter randomized controlled trial. A total of 148 CSAP patients will be randomly allocated into two groups through central randomization in a 1:1 ratio. This trial will include a 2-week screening period, a 4-week treatment period, and a 4-week follow-up period. The primary outcome is the frequency of angina attacks from baseline to 4 weeks after inclusion. Secondary outcomes include the frequency of angina attacks from baseline to 4 weeks after acupuncture treatment, the pain intensity of angina, total ischemia burden, heart rate variability, QT dispersion, the score of Seattle Angina Questionnaire, and the score of Short-Form of McGill Pain Questionnaire. These outcome measures will be evaluated at baseline, at the end of acupuncture treatment, and at the end of follow-up.
We hypothesize that the effectiveness of puncturing at acupoints on the Heart Meridian will not be the same as those on the Lung Meridian. The results will provide further evidence of Meridian-Viscera Association theory and references for acupoints selection in the clinical practice.
Chinese Clinical Trial Registry ChiCTR1900025804 . Registered on September 9, 2019.
针刺疗法长期以来一直被用于治疗慢性稳定型心绞痛(CSAP),但 CSAP 的针刺处方各不相同。本试验将比较心经穴位与肺经穴位治疗 CSAP 的疗效,为针刺治疗 CSAP 提供更好的处方。
这是一项多中心随机对照试验。将 148 例 CSAP 患者通过中心随机化以 1:1 的比例随机分为两组。本试验包括 2 周的筛选期、4 周的治疗期和 4 周的随访期。主要结局是从基线到纳入后 4 周心绞痛发作的频率。次要结局包括从基线到针刺治疗后 4 周心绞痛发作的频率、心绞痛疼痛强度、总缺血负荷、心率变异性、QT 离散度、西雅图心绞痛问卷评分和 McGill 疼痛问卷短表评分。这些结局指标将在基线、针刺治疗结束时和随访结束时进行评估。
我们假设针刺心经穴位的疗效与针刺肺经穴位的疗效不同。研究结果将为经络脏腑相关理论提供进一步的证据,并为临床实践中的穴位选择提供参考。
中国临床试验注册中心 ChiCTR1900025804。注册于 2019 年 9 月 9 日。